Immunology is the study of the immune system and the body’s ability to protect itself from infection: If the immune system cannot respond appropriately, then it can result in serious and life-threatening conditions including asthma, diabetes, rheumatoid arthritis, celiac disease, and immune deficiency disorders such as AIDS. In addition, cancer immunologists investigate how the immune system’s interactions with tumor cells can be enlisted in the body’s battle against cancer. To perform your reproducible research, you need access to a wide variety of authenticated, reliable materials for accurate research results.
ATCC supplies numerous cell lines, primary cells, iPSC-derived differentiated cells, microbial pathogens, cell culture reagents, and non-cellular immunogens for the advancement of immunological research areas, including antigen presentation, lymphocyte maturation, vaccine production, T cell suppression, and liquid tumor cancers.
We provide an extensive variety of cultures, reagents, and services useful for this important area of research, including primary mononuclear cells and lymphocytes, leukemia and lymphoma cell lines, primary CD14+ monocytes and CD34+ hematopoietic cells, viruses, bacteria, fungi, and protozoa. We also offer polysaccharides, nucleic acids, and toxins.
Download Information on ATCC Cancer Immunology Research Tools
DOWNLOADNatural killer cells
Natural killer (NK) cells were first identified for their ability to kill tumor cells without activation. NK cells are a focus of many cancer immunotherapies, as they display rapid and potent immunity to metastasis or hematological cancers. Measuring the activity of natural killer cells is necessary for many immune applications.
Download the Application NoteDiscover how our immunological cells improve studies of cardiovascular systems
Differentiated iPSCs
Immunologists, toxicologists, and cancer researchers alike are challenged by the lack of a consistent source of cells with high physiological relevance for their cell-based assays. To address this need, ATCC differentiated its iPSCs into three types of biologically relevant cells: CD34+ progenitors, mesenchymal stem cells (MSCs), and monocytes.
- Can be differentiated into your desired cell type
- Ideal for cell-based assay development
- Provides a virtually unlimited source of cells
- Eliminates donor variability
- Offers high interexperimental reproducibility
- Predictive of the in vivo situation
